Can glomerulosclerosis be reversed? (Q80166821)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932443%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Can glomerulosclerosis be reversed? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932443%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Agnes B Fogo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932443%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932443%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Nephrology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932443%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932443%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932443%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

290-291

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932443%20AND%20SRC:MED&resulttype=core&format=json

Progression and potential regression of glomerulosclerosis

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0200

7 January 2021

Reversal of Glomerulosclerosis after High-Dose Enalapril Treatment in Subtotally Nephrectomized Rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0200

7 January 2021

Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0200

7 January 2021

How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0200

7 January 2021

An extremely high dose of losartan affords superior renoprotection in the remnant model

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0200

7 January 2021

Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0200

7 January 2021

Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0200

7 January 2021

Regression of existing glomerulosclerosis by inhibition of aldosterone

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0200

7 January 2021

Identifiers

DOI

10.1038/NCPNEPH0200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932443%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference